<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormal gene promoter methylation contributes to deregulate gene expression of hematopoietic progenitors in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed the gene expression profile of myelodysplastic and <z:mpath ids='MPATH_458'>normal</z:mpath> CD34+ hematopoietic stem cells (<z:chebi fb="15" ids="50443">HSCs</z:chebi>) treated in vitro with <z:chebi fb="0" ids="50131">decitabine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>We identified a list of candidate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes, expressed at low levels in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> <z:chebi fb="15" ids="50443">HSCs</z:chebi> and induced by hypomethylating treatment only in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, but not in <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="15" ids="50443">HSCs</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Real-time RT-PCR confirmed reduced CD9 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> CD34+ and bone marrow mononuclear cells, compared to <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="4" pm="."><plain>CD9 was specifically up-regulated by <z:chebi fb="0" ids="50131">decitabine</z:chebi> treatment in myelodysplastic CD34+ cells </plain></SENT>
</text></document>